Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants

Five DNA vaccine candidates based on different SARS-CoV-2 strains.

Organigram Q3 Revenue Declines 17% Sequentially

Organigram Reports Third Quarter Fiscal 2023 Results Year-to-date Canadian recreational business grew 10% versus prior year driven by continued focus on consumer-centric products and brands

July 14, 2023

Docs’ Ketamine Scheme Accusation; Texas Doc Wins Snake Case; Maternal Death Suit

Two doctors in Missouri have been charged with illegally administering ketamine and fraudulently billing Medicare, according to federal prosecutors. The Texas Supreme Court has sided

January 19, 2024

Replicate’s srRNA rabies vaccine effective in Phase 1

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! And it’s Meghana

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.